Corporate Grants: Cancer - Onyx Pharmaceuticals Onyx Pharmaceuticals is committed to developing therapeutics that improve the lives of individuals with cancer. Our lead product is Nexavar® (sorafenib) tablets, an oral, targeted therapy for the treatment of patients with liver cancer and advanced kidney cancer. Onyxgrant.com~Site InfoWhoisTrace RouteRBL Check
THE SIRveNIB Trial The SIRveNIB Trial - providing you with information about primary liver cancer (hepatocellular carcinoma or HCC) and the clinical trial SIRveNIB for liver cancer patients in the Asia Pacific region. Our goal is to provide liver cancer patients and their families with relevant knowledge of liver cancer and with information of this clinical trial (SIRveNIB). Sirvenib.com~Site InfoWhoisTrace RouteRBL Check
Anastrozole|Bortezomib|Calcitriol|Flavopiridol|Lapatinib|Palonosetron|Sorafenib|Trifuridine|Esun Chemical Zhejiang Esun Chemical Co., Ltd. is an independent and fast growing company specialized in developing and marketing new-type pharmaceuticals and intermediates.We can supply Sorafenib,Lapatinib Ditosylate, Erlotinib hydrochloride, Sunitinib malate,Bicalutamide, Imatinib Mesylate, Palonosetron, ilotinib, Lapatinib,Darifenacin, Gefitinib, Pregabalin, Mofegiline, Anastrozole, Rubitecam,Montelukast, Calcipotriol, Calcipotriene, Lenalidomide, Alfacalcidol,Calcitriol, Flavopiridol etc. Esunchem.com~Site InfoWhoisTrace RouteRBL Check
